STOCK TITAN

Axon Enterprise (NASDAQ: AXON) awards CLO 10,488 performance shares

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

AXON ENTERPRISE, INC. reported that Chief Legal Officer Isaiah Fields acquired 10,488 shares of common stock via vesting of performance-based restricted stock units (XSUs). These units were originally granted on December 22, 2023 under the 2024 eXponential Stock Plan after the Compensation Committee certified performance for the fourth tranche on August 16, 2026.

The tranche is scheduled to vest on December 1, 2026, subject to continued employment, and the resulting shares are subject to a minimum holding period until the earlier of December 31, 2030 or a subsequent tranche vesting, excluding any shares withheld or sold for taxes. Following this award, Fields directly holds 58,044.014 shares of Axon common stock.

Positive

  • None.

Negative

  • None.
Insider Fields Isaiah
Role Chief Legal Officer
Type Security Shares Price Value
Grant/Award Common Stock F1 10,488 $0.00 $0.00
Holdings After Transaction: Common Stock — 58,044.014 shares (Direct)
Footnotes (1)
  1. F1. The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on December 22, 2023 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the fourth tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on August 16, 2026 as having been met. The Tranche will vest on December 1, 2026, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes.
Shares acquired 10,488 shares Performance-based restricted stock units (fourth tranche of XSUs) becoming earned
Post-transaction holdings 58,044.014 shares Total AXON common stock directly held by Isaiah Fields after the reported award
Vesting date December 1, 2026 Scheduled vesting date of the reported XSU tranche, subject to continued employment
Holding period end date December 31, 2030 Latest date for minimum holding period on delivered tranche shares, unless a later tranche vests earlier
Grant date of XSUs December 22, 2023 Original grant date of the performance-based restricted stock units under the 2024 eXponential Stock Plan
Performance certification date August 16, 2026 Date the Compensation Committee certified performance conditions for the fourth XSU tranche
performance-based restricted stock units financial
"The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted"
Performance-based restricted stock units are a type of employee equity award that converts into company shares only if predefined financial or operational targets are met over a set period. Think of it like a bonus check that becomes stock only when specific goals are hit; it ties pay to results, aligning managers’ incentives with shareholders. Investors care because these awards affect future share count, executive incentives, and signal how management’s success will be measured and rewarded.
2024 eXponential Stock Plan financial
"granted on December 22, 2023 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan"
Compensation Committee financial
"were certified by the issuer's Compensation Committee of the Board of Directors"
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.
minimum holding period financial
"shares deliverable for the Tranche are subject to a minimum holding period until"

FAQ

What did AXON (AXON) disclose about Isaiah Fields in this Form 4?

AXON disclosed that Chief Legal Officer Isaiah Fields acquired 10,488 shares of common stock through performance-based restricted stock units. These shares relate to the fourth tranche of XSUs granted under the 2024 eXponential Stock Plan after performance conditions were certified.

How many AXON (AXON) shares does Isaiah Fields hold after this transaction?

After this transaction, Isaiah Fields beneficially holds 58,044.014 shares of AXON common stock. This reflects the addition of 10,488 shares tied to the certified performance-based restricted stock unit tranche reported in the Form 4.

What kind of equity award did Isaiah Fields receive from AXON (AXON)?

Isaiah Fields received performance-based restricted stock units (XSUs) that convert into 10,488 AXON common shares. The award was granted under the 2024 eXponential Stock Plan and became earned when performance for the fourth tranche was certified.

When will the reported AXON (AXON) XSU tranche for Isaiah Fields vest?

The reported XSU tranche for Isaiah Fields will vest on December 1, 2026, subject to continued employment through that date. Only after this vesting will the 10,488 shares be delivered, with additional holding-period restrictions then applying.

What holding restrictions apply to Isaiah Fields’ new AXON (AXON) shares?

After vesting, the shares from this tranche are subject to a minimum holding period until the earlier of December 31, 2030 or the vesting of a subsequent XSU tranche. Shares withheld or sold to cover taxes are excluded from this requirement.

Were Isaiah Fields’ AXON (AXON) transactions under a Rule 10b5-1 plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox is not marked, so this award recognition is not reported as occurring under a pre-arranged trading plan. It reflects certification and vesting mechanics of an existing performance-based award.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fields Isaiah

(Last)(First)(Middle)
17800 N 85TH ST

(Street)
SCOTTSDALE ARIZONA 85255

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Legal Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/16/2026A(1)10,488A$058,044.014D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on December 22, 2023 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the fourth tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on August 16, 2026 as having been met. The Tranche will vest on December 1, 2026, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes.
Remarks:
Isaiah Fields08/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)